MENU
등록일 | 제목 | 작성자 |
---|---|---|
2020-04-13 | Celltrion Group’s Statement on the development of a therapeutic antibody treatment to combat COVID-19 | Celltrion Healthcare |
2018-12-11 | [Notice to shareholders] Celltrion Healthcare’s Statement on press release from YTN | Celltrion Healthcare |
2018-11-19 | Biosimilars have the potential to deliver dramatic cost savings for US and European healthcare systems | Celltrion Healthcare |
2018-05-21 | Biosimilars could facilitate early access to life changing biological treatments for patients says Celltrion Healthcare | Celltrion Healthcare |
2018-02-15 | Celltrion’s Herzuma® (biosimilar trastuzumab) approved in Europe | Celltrion Healthcare |
2016-12-27 | Celltrion Healthcare website renewed | Celltrion Healthcare |